JP2010511694A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010511694A5 JP2010511694A5 JP2009539869A JP2009539869A JP2010511694A5 JP 2010511694 A5 JP2010511694 A5 JP 2010511694A5 JP 2009539869 A JP2009539869 A JP 2009539869A JP 2009539869 A JP2009539869 A JP 2009539869A JP 2010511694 A5 JP2010511694 A5 JP 2010511694A5
- Authority
- JP
- Japan
- Prior art keywords
- halogen
- growth factor
- receptor
- factor receptor
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87251106P | 2006-12-04 | 2006-12-04 | |
| PCT/IL2007/001494 WO2008068751A1 (en) | 2006-12-04 | 2007-12-04 | Novel protein kinase modulators and therapeutic uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010511694A JP2010511694A (ja) | 2010-04-15 |
| JP2010511694A5 true JP2010511694A5 (https=) | 2012-02-02 |
Family
ID=39111493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009539869A Pending JP2010511694A (ja) | 2006-12-04 | 2007-12-04 | 新規なタンパク質キナーゼ修飾因子および治療におけるその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8058309B2 (https=) |
| EP (1) | EP2125712B1 (https=) |
| JP (1) | JP2010511694A (https=) |
| CN (1) | CN101652345A (https=) |
| AU (1) | AU2007330333A1 (https=) |
| BR (1) | BRPI0719708A2 (https=) |
| CA (1) | CA2671632A1 (https=) |
| WO (1) | WO2008068751A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2758016A1 (en) * | 2008-06-05 | 2009-12-10 | Novotyr Therapeutics Ltd. | Novel modulators of protein kinase signaling |
| ES2566673T3 (es) | 2010-12-27 | 2016-04-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Derivados 2-(2-feniletenilo)-1,3-benzotiazol útiles para el tratamiento del cáncer |
| WO2012117396A1 (en) | 2011-03-01 | 2012-09-07 | Novotyr Therapeutics Ltd | Tyrphostin derivative in combination with cytotoxic compounds for treating cancer |
| EP3021944B1 (en) * | 2013-07-14 | 2018-12-19 | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. | Igf-1r signaling pathway inhibitors useful in the treatment of neurodegenerative diseases |
| CN107250108B (zh) * | 2015-02-05 | 2020-11-27 | 特尔诺沃有限公司 | 用于治疗癌症的irs/stat3双重调节剂与抗癌剂的组合 |
| WO2019097503A1 (en) | 2017-11-16 | 2019-05-23 | Tyrnovo Ltd. | Combinations of irs/stat3 dual modulators and anti pd-1/pd-l1 antibodies for treating cancer |
| WO2019246273A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a jak or other kinase inhibitor |
| CN115466205B (zh) * | 2021-11-04 | 2023-10-24 | 特尔诺沃有限公司 | 分离的3-（2-溴-3,4-二羟基-苯基）-n-（3,4,5-三羟基-苄基）-硫代丙烯酰胺的反式异构体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5217999A (en) | 1987-12-24 | 1993-06-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Styryl compounds which inhibit EGF receptor protein tyrosine kinase |
| WO1995024190A2 (en) * | 1994-03-07 | 1995-09-14 | Sugen, Inc. | Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof |
| US20040197335A1 (en) * | 2001-06-14 | 2004-10-07 | Shimon Slavin | Non-myeloablative tolerogenic treatment with tyrphostins |
| CA2466928A1 (en) * | 2001-12-10 | 2003-07-03 | Yansheng Du | Treatment of neurodegenerative and cardiovascular disorders |
| WO2003101927A1 (en) * | 2002-05-31 | 2003-12-11 | Proteotech, Inc. | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
-
2007
- 2007-12-04 US US12/517,278 patent/US8058309B2/en active Active
- 2007-12-04 JP JP2009539869A patent/JP2010511694A/ja active Pending
- 2007-12-04 CA CA002671632A patent/CA2671632A1/en not_active Abandoned
- 2007-12-04 CN CN200780050587A patent/CN101652345A/zh active Pending
- 2007-12-04 AU AU2007330333A patent/AU2007330333A1/en not_active Abandoned
- 2007-12-04 BR BRPI0719708-0A2A patent/BRPI0719708A2/pt not_active Application Discontinuation
- 2007-12-04 WO PCT/IL2007/001494 patent/WO2008068751A1/en not_active Ceased
- 2007-12-04 EP EP07827467.7A patent/EP2125712B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010511694A5 (https=) | ||
| CN104395308B (zh) | N-[5-(3,5-二氟-苄基)-1h-吲唑-3-基]-4-(4-甲基-哌嗪-1-基)-2-(四氢-吡喃-4-基氨基)-苯甲酰胺的制备方法 | |
| DK2380881T3 (en) | NEW BICYCLIC HETEROCYCLIC COMPOUND | |
| JP5204091B2 (ja) | 新規なベンジル（ヘテロサイクリックメチル）アミン構造を有するピリミジン化合物及びこれを含有する医薬 | |
| JP2009513703A5 (https=) | ||
| JP6896701B2 (ja) | イミダゾリルアミド誘導体 | |
| JP2014193925A5 (https=) | ||
| JP2009536191A5 (https=) | ||
| WO2019143860A1 (en) | 5-fluorouracil compounds | |
| US10774079B2 (en) | Quinazoline derivative | |
| CN110770234B (zh) | 取代芳基醚类化合物、其制备方法、药用组合物及其应用 | |
| WO2016208592A1 (ja) | 二環性複素環アミド誘導体 | |
| JP2007523177A5 (https=) | ||
| TW202214626A (zh) | 雌激素受體調節劑化合物及其用途 | |
| US20200399227A1 (en) | 5-fluorouracil compounds | |
| RU2483064C2 (ru) | Твердые формы ингибитора raf-киназы | |
| CN110054584B (zh) | 1-芳基-3-{4-[(吡啶-2-基甲基)硫基]苯基}脲类化合物及应用 | |
| TW202031653A (zh) | 新穎雜環芳香族醯胺衍生物及含有其之醫藥 | |
| TWI864050B (zh) | 環狀去氧核糖核苷酸化合物 | |
| JP5701387B2 (ja) | ベルバミンのジカルボキシミド誘導体、その調製方法及び使用 | |
| JP6533997B2 (ja) | Ｚｎｆ１４３阻害活性を有する化合物およびその利用 | |
| EP4646402A1 (en) | Gpr35 modulators | |
| WO2023177351A1 (en) | Nf қb inducing kinase inhibitors and methods thereof | |
| KR102205619B1 (ko) | 신규한 인다졸 유도체 화합물 및 이를 포함하는 암의 예방, 개선 또는 치료용 약학 조성물 | |
| CN111892536B (zh) | 取代的喹啉甲酰胺类化合物及其用途 |